VIDRL Mycobacterium Reference Laboratory

Quarterly Surveillance Report - Fourth Quarter 2002


*Due to the slow growing nature of Mycobacteria spp. this report will always be presented with a one period delay to maintain accuracy

Specimen Analysis

Most specimens (both primary & referred) and isolates are from Victorian patients. The majority of non-Victorian patients originate in the Northern Territory & the Solomon Islands

Primary Specimens
M. tb isolates
New Victorian M tb isolates
Non M. tb isolates
Negatives
Total
October
35
10
17
459
588
November
7
2
24
494
525
December
27
11
17
452
496
Referred Specimens
October
32
18
56
88
November
26
14
58
84
December
25
18
42
67
61
 
Total
152
73
214
1405
1771

 

 

 

Site details of M. tuberculosis isolates and resistant isolates by month

October
November
December
Site
Pulmonary
14
7
15
Extrapulmonary
15
9
13
 
Extrapulmonary Site Details

Lymph node (x4),
Neck abscess (x2),
Urine (x2),
CSF (x1),
Spinal tissue (x1),
Caecum bx (x1),
Axilla abscess (x1),
Abdo. Mass (x1),
Elbow asp (x1),
Hip tissue (x1)

Lymph node (x1),
Neck asp (x1),
Urine (x2),
Pectoral cyst (x1),
Thoracic paraspinal mass (x1),
Perifracheal tiss (x1),
Caecum swab (x1)

Lymph node (x6),
Urine (x3),
Pleural fluid (x2),
Groin asp. (x1),
Ascitic
Resistance 1x resistance to Isoniazid,
1x resistance to Isoniazid & Streptomycin
1x resistance to Isoniazid & Streptomycin,
1x resistance to Isoniazid, Streptomycin & Rifampicin

1x resistance to
Isoniazid & Streptomycin

 

Direct Amplification (MTD)

 
October
November
December
Fresh Specimens      
Positive
3
-
2
Positive - culture negative
-
1
(TB pos in 1995)
-
Negative - culture positive
2
1
-
Negative
48
34
29
Total
53
36
31
Paraffin Embedded Specimens
Positive
2
-
1
Negative
10
7
6
Total
12
7
7

 

Comments

M. bovis was isolated from sputum of a 54 year old male residing in the Northern Territory.

M. bovis BCG was recovered from a vaccination site and an axillary lymph node of two vaccinated infants.

M. abscessus which can cause pulmonary disease was isolated from sputum specimens of 4 males aged from 23 to 77. Three had multiple isolations and one has had the organism isolated every year since 1998.

M. fortuitum was isolated from a leg wound of a 47 year old man.

Mycobacterium kansasii was isolated for the first time from respiratory specimens of one elderly female & 2 males. One male had multiple isolations and concurrent infection with M. avium complex.

Mycobacterium marinum was recovered from the upper extremities of 3 female patients aged between 14 & 57. Two patients gave histories of keeping tropical fish.

M.ulcerans PCR was requested on 75 specimens, including 1 specimen from a ringtail possum. There were 13 positive results from 12 different patients. This represented 10 new bases and included the possum and one case from Queensland. The PCR cases from the new cases were confirmed by culture. There were also 3 new M.ulcerans isolations where PCR was not requested, one from a patient in Western Australia. This represents the first isolation of M. ulcerans from that state.

Molecular identification techniques were used to identify or confirm identification of 71 isolates, including M.asiaticum, M.heckeshornense and M. shimoidei from 2 patients each. Overall 20 mycobacterial species were identified as well as 9 Nocardia spp. & 3 Streptomyces spp.

Mycobacterium generic PCR was performed on 24 specimens, including 12 paraffin embedded specimens. M.tuberculosis was detected in two paraffin embedded specimens and one sputum. M.avium was identified from a fresh lymph node biopsy.